Dissecting the functional role of APOBEC3B in multiple myeloma

Basic Information

Funding Cycle : 2022-2023
Name : Florian Kuchenbauer
Type of Award : Translational Research Award
Home Institution : Terry Fox Laboratory, BC Cancer Research Institute, Canada


AIM 1 aims to identify APOBEC3B (A3B) targets and pathways affected in multiple myeloma (MM) cells. Using knockdown and overexpression techniques, researchers will assess the functional impact of A3B on MM cell viability, proliferation, apoptosis, and DNA damage. RNA-Seq and proteomics will provide mechanistic insights into A3B’s role in MM, potentially identifying affected pathways. AIM 2 involves studying A3B’s impact on MM progression in vivo using mouse models, complementing findings from human cell lines. AIM 3 focuses on targeting A3B activity with small molecule inhibitors, aiming to prevent drug resistance and tumor recurrence. Treatment with inhibitors will be evaluated in MM cell lines and mouse models, assessing cell behavior and disease progression. This comprehensive approach seeks to elucidate A3B’s role in MM and explore its therapeutic potential.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events